Compare Johnson & Johnson (JNJ) vs PulteGroup, Inc. (PHM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs PulteGroup, Inc. — how do they compare? Johnson & Johnson trades at $260.35 (market cap $626.09B), while PulteGroup, Inc. trades at $128.42 (market cap $25.22B). The key difference: Johnson & Johnson is far larger — about 24.8× PulteGroup, Inc.'s market cap, and Johnson & Johnson pays the higher dividend (2.06%). Which is the better fit depends on your goals.
| JNJ | PHM | |
|---|---|---|
Market Cap | $626.09B | $25.22B |
Volume | 6,156,228 | — |
Sector | Health | Consumer Cyclical |
52-Week High | $267.24 | $142.56 |
52-Week Low | $172.78 | $110.11 |
Enterprise Value | $654.37B | $25.64B |
Dividend Yield | 2.06% | 0.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $261.81, up 0.99% on the day and near its 52-week high. The stock exhibits bullish technical signals with strong moving average support, while fundamentals show robust profitability with a net income margin of 21.48% and consistent dividend growth. Recent earnings have mostly beaten expectations, and the company maintains a solid balance sheet with $24.52 billion in cash.
The outlook for JNJ remains positive, supported by analyst consensus and a price target of $284.50. Key opportunities include its defensive healthcare positioning and pipeline strength, though risks involve patent expirations and legal headwinds. The stock offers a stable investment with growth potential in a volatile market.
PulteGroup (PHM) trades at $130.05, down 2.14% on the day, with a bullish technical signal from moving averages and neutral oscillators. The stock shows mixed earnings performance, beating Q2 2026 estimates but missing in Q4 2025 and Q1 2026. Recent news highlights operational expansion into Northwest Florida and corporate recognition as a Great Place to Work, while financials indicate solid profitability with an 11.62% net margin and a P/E of 13.53.
Outlook remains cautiously optimistic with a consensus price target of $137.20, suggesting modest upside. Risks include margin pressure from housing market affordability challenges and volatile cash flows. Institutional sentiment leans neutral with 50% hold ratings, reflecting balanced Wall Street views amid industry headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About PulteGroup, Inc.
PulteGroup Inc is one of the largest homebuilders in the United States, operating in 40 markets across 23 states. The company mainly builds single-family detached homes (85% of unit sales) and offers products to entry-level, move-up, and active-adult buyers. PulteGroup offers homebuyers mortgage financing and title agency services through its financial services segment. The company is headquartered in Atlanta.
Read more on PHM →
